Analystreport

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) had its price target lowered by analysts at HC Wainwright from $20.00 to $13.00.

Sorrento Therapeutics, Inc.  (SRNE) 
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm Check Earnings Report
US:NASDAQ Investor Relations: sorrentotherapeutics.com/investors